Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion.

Sun M, Liu C, Nadiminty N, Lou W, Zhu Y, Yang J, Evans CP, Zhou Q, Gao AC.

Prostate. 2012 Jan;72(1):82-9. doi: 10.1002/pros.21409. Epub 2011 May 2.

2.

The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.

Teng Y, Ross JL, Cowell JK.

JAKSTAT. 2014 Jan 1;3(1):e28086. doi: 10.4161/jkst.28086. Epub 2014 Feb 20. Review.

3.

Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives.

Gaziano R, Moroni G, Buè C, Miele MT, Sinibaldi-Vallebona P, Pica F.

World J Gastrointest Oncol. 2016 Jan 15;8(1):30-9. doi: 10.4251/wjgo.v8.i1.30. Review.

4.

How should we define STAT3 as an oncogene and as a potential target for therapy?

Sellier H, Rébillard A, Guette C, Barré B, Coqueret O.

JAKSTAT. 2013 Jul 1;2(3):e24716. doi: 10.4161/jkst.24716. Epub 2013 Apr 16. Review.

Supplemental Content

Support Center